Abcellera Biologics Inc Cash Flow Reinvestment Rate
Abcellera Biologics Inc cash flow reinvestment rate. Abcellera Biologics Inc (ABCL) has a Cash Flow Reinvestment Rate of 1.89x as of June 2023, reinvesting $37.52 Million (capex $27.35 Million plus investments $-10.17 Million) from operating cash flow of $19.82 Million. See how financially flexible is Abcellera Biologics Inc to measure the company's free cash flow as a share of total liabilities.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Abcellera Biologics Inc (2018–2022)
Cash flow reinvestment rate of Abcellera Biologics Inc from 2018 to 2022. Historical reinvestment intensity for Abcellera Biologics Inc across 5 annual periods. Explore how well can Abcellera Biologics Inc service its debt to assess how comfortably operating cash covers total debt obligations.
Abcellera Biologics Inc Cash Flow Reinvestment Rate by Year (2018–2022)
Abcellera Biologics Inc cash flow reinvestment rate by year from 2018 to 2022. Year-by-year capital reinvestment analysis for Abcellera Biologics Inc. For the full cash flow conversion analysis, see Abcellera Biologics Inc (ABCL) cash flow conversion.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2022 | 1.53x | $425.29 Million | $277.36 Million | $72.66 Million | ▲ +11.7% |
| 2021 | 1.37x | $335.88 Million | $244.58 Million | $58.45 Million | ▼ -8.1% |
| 2020 | 1.49x | $33.92 Million | $22.69 Million | $14.67 Million | ▼ -58.8% |
| 2019 | 3.63x | $9.78 Million | $2.69 Million | $4.00 Million | ▲ +21.9% |
| 2018 | 2.98x | $10.61 Million | $3.56 Million | $5.31 Million | — |